CORBION NV (CRBN.AS) Stock Fundamental Analysis
Europe - Euronext Amsterdam - AMS:CRBN - NL0010583399 - Common Stock
18.57 EUR
+0.11 (+0.6%)
Taking everything into account, CRBN scores 5 out of 10 in our fundamental rating. CRBN was compared to 68 industry peers in the Chemicals industry. CRBN has an average financial health and profitability rating. CRBN has a bad growth rate and is valued cheaply. This makes CRBN very considerable for value investing!
1. Profitability
1.1 Basic Checks
CRBN had positive earnings in the past year.
CRBN had a positive operating cash flow in the past year.
Each year in the past 5 years CRBN has been profitable.
In the past 5 years CRBN always reported a positive cash flow from operatings.
1.2 Ratios
CRBN has a better Return On Assets (4.55%) than 69.12% of its industry peers.
With a decent Return On Equity value of 9.12%, CRBN is doing good in the industry, outperforming 67.65% of the companies in the same industry.
With a decent Return On Invested Capital value of 9.19%, CRBN is doing good in the industry, outperforming 75.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 7.01%.
The 3 year average ROIC (6.62%) for CRBN is below the current ROIC(9.19%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROIC | 9.19% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
1.3 Margins
CRBN has a Profit Margin of 5.11%. This is in the better half of the industry: CRBN outperforms 64.71% of its industry peers.
CRBN's Profit Margin has improved in the last couple of years.
CRBN's Operating Margin of 8.68% is fine compared to the rest of the industry. CRBN outperforms 63.24% of its industry peers.
In the last couple of years the Operating Margin of CRBN has declined.
With a Gross Margin value of 26.10%, CRBN is not doing good in the industry: 63.24% of the companies in the same industry are doing better.
CRBN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% |
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRBN is creating some value.
CRBN has less shares outstanding than it did 1 year ago.
CRBN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRBN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.74 indicates that CRBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.74, CRBN perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
CRBN has a debt to FCF ratio of 4.95. This is a neutral value as CRBN would need 4.95 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.95, CRBN is doing good in the industry, outperforming 72.06% of the companies in the same industry.
CRBN has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
CRBN's Debt to Equity ratio of 0.39 is in line compared to the rest of the industry. CRBN outperforms 55.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Altman-Z | 2.74 |
ROIC/WACC1.46
WACC6.31%
2.3 Liquidity
CRBN has a Current Ratio of 1.21. This is a normal value and indicates that CRBN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CRBN (1.21) is worse than 83.82% of its industry peers.
A Quick Ratio of 0.60 indicates that CRBN may have some problems paying its short term obligations.
CRBN has a Quick ratio of 0.60. This is amonst the worse of the industry: CRBN underperforms 91.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
CRBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.99%.
Measured over the past years, CRBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 49.47% on average per year.
CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.95%.
Measured over the past years, CRBN shows a small growth in Revenue. The Revenue has been growing by 5.70% on average per year.
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
3.2 Future
CRBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.24% yearly.
Based on estimates for the next years, CRBN will show a decrease in Revenue. The Revenue will decrease by -1.71% on average per year.
EPS Next Y36.6%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
EPS Next 5Y15.24%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.58, which indicates a correct valuation of CRBN.
73.53% of the companies in the same industry are more expensive than CRBN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.77, CRBN is valued a bit cheaper.
CRBN is valuated correctly with a Price/Forward Earnings ratio of 12.20.
Based on the Price/Forward Earnings ratio, CRBN is valued cheaper than 80.88% of the companies in the same industry.
CRBN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.58 | ||
| Fwd PE | 12.2 |
4.2 Price Multiples
CRBN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 66.18% of the companies in the same industry.
CRBN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRBN is cheaper than 91.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.84 | ||
| EV/EBITDA | 7.75 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRBN may justify a higher PE ratio.
A more expensive valuation may be justified as CRBN's earnings are expected to grow with 19.62% in the coming years.
PEG (NY)0.45
PEG (5Y)0.34
EPS Next 2Y22.97%
EPS Next 3Y19.62%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.52%, CRBN has a reasonable but not impressive dividend return.
CRBN's Dividend Yield is a higher than the industry average which is at 2.51.
Compared to an average S&P500 Dividend Yield of 2.00, CRBN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.52% |
5.2 History
The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
5.3 Sustainability
CRBN pays out 56.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP56.19%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
AMS:CRBN (12/31/2025, 1:53:46 PM)
18.57
+0.11 (+0.6%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners90.59%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.08B
Revenue(TTM)1.30B
Net Income(TTM)66.20M
Analysts78.57
Price Target23.92 (28.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.52% |
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.19%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.51%
PT rev (3m)2.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)-1.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.58 | ||
| Fwd PE | 12.2 | ||
| P/S | 0.83 | ||
| P/FCF | 10.84 | ||
| P/OCF | 6.42 | ||
| P/B | 1.49 | ||
| P/tB | 1.71 | ||
| EV/EBITDA | 7.75 |
EPS(TTM)1.12
EY6.03%
EPS(NY)1.52
Fwd EY8.2%
FCF(TTM)1.71
FCFY9.23%
OCF(TTM)2.89
OCFY15.58%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.45
PEG (5Y)0.34
Graham Number17.72
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROCE | 10.92% | ||
| ROIC | 9.19% | ||
| ROICexc | 9.57% | ||
| ROICexgc | 10.55% | ||
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% | ||
| FCFM | 7.7% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Debt/EBITDA | 1.43 | ||
| Cap/Depr | 81.01% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | 7.03 | ||
| Cash Conversion | 85.4% | ||
| Profit Quality | 150.76% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.74 |
F-Score6
WACC6.31%
ROIC/WACC1.46
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.6%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.53%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year128.83%
EBIT Next 3Y37.35%
EBIT Next 5Y26.73%
FCF growth 1Y171.85%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y118.83%
OCF growth 3Y101.81%
OCF growth 5Y9.98%
CORBION NV / CRBN.AS FAQ
What is the fundamental rating for CRBN stock?
ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.
Can you provide the valuation status for CORBION NV?
ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.
What is the profitability of CRBN stock?
CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for CRBN stock?
The Price/Earnings (PE) ratio for CORBION NV (CRBN.AS) is 16.58 and the Price/Book (PB) ratio is 1.49.
Can you provide the dividend sustainability for CRBN stock?
The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.19%.